Manus $500M Funding Round Shows China's Rules for AI Capital

What happened

Butterfly Effect, the parent of the general-purpose AI agent Manus, has closed a funding round of more than $500 million. Private equity firm Boyu Capital and venture investor IDG Capital led the round. Existing backers Tencent, HSG and ZhenFund also put in more money. 124 The company announced the round on October 8, 2026. It is Manus's first outside financing since Chinese regulators forced Meta Platforms to walk away from its roughly $2 billion acquisition of the startup. 24

The round is being described as the largest single investment ever raised in China's AI application sector. 1 The company resumed independent operations on September 1. Alongside the funding news, it posted 17 job openings across product development, operations and commercialization. 1

The valuation question

The accounts differ on valuation. One report presents a target of about $4 billion as the round's goal. That figure is double the price at which the founders and existing shareholders bought the company back from Meta. 1 Other coverage is more careful. It credits the $4 billion figure to a Bloomberg report from the previous month and notes that Butterfly Effect has not disclosed or confirmed a post-money valuation. 24 If the number holds, it would make Manus China's most valuable AI agent maker. 4

The company also has not said how it plans to spend the money. 2 For now, the $4 billion figure is best read as a widely reported target, not a confirmed result.

A round trip in fifteen months

The funding only makes sense against the unusual year Manus has had. In December 2025, Manus said its annual recurring revenue had passed $100 million, just eight months after launch. Meta agreed to buy it that same month. 3

Beijing then stepped in:

• January 8: China's Ministry of Commerce said it would examine whether the deal complied with rules on export controls, technology transfer and outbound investment. 3
• April 27: The National Development and Reform Commission ordered the transaction unwound on national security grounds. 3

Law firms noted that this was the first time China had reversed a completed deal under its foreign investment security review rules. 3 The company had also moved its legal home to Singapore. As one analysis put it, that move bought time, not freedom. 3

Who wrote the check, and why it matters

The most telling detail is the nationality of the investors, more than the size of the round. Every named participant is a Chinese firm or a Chinese-founded fund, and several were already shareholders before the Meta deal. One commentary argues that Western funds were never realistic rescuers for a company being watched by both Washington and Beijing. In its view, the money naturally came from the same Chinese investors who were on the cap table before the founders left. 3

Coverage reads the raise in two ways that don't conflict. One reading is that investors are not scared off by Beijing's unprecedented intervention. 4 The other is that the round boosts confidence in China's AI application startups at a time when competition among agent makers is increasingly a contest between tech giants. 1

Our reading puts the emphasis differently. The round shows that capital can still flow freely to a Chinese AI champion, but along a narrow path that Beijing has now marked out clearly. A sale to an American tech giant was blocked and reversed. A fully domestic recapitalization by familiar investors appears to have gone ahead without public obstacle. For founders weighing an offshore structure or a foreign buyer, the lesson is that a redomicile does not change where regulators think a company's technology and talent belong.

This is analysis, not a stated policy. Beijing has not published a rulebook saying which investors are acceptable. But the sequence is hard to miss: a foreign acquisition was unwound, and a homegrown round followed within weeks of the company regaining independence.

What Manus still has to prove

The money does not settle the business question. Manus still needs to show that its "general agent" approach can produce lasting willingness to pay and real commercial value. 1 Its early revenue figure was striking. 3 But it now faces deep-pocketed rivals while rebuilding after months of regulatory limbo, and the hiring push suggests it is restaffing to compete. 1

Investors are betting the agent market will reward a focused independent player. Beijing is signaling that such a player should stay in Chinese hands. Whether Manus can grow into a $4 billion valuation under those terms is the next test.